CEO Jean Jacques Bienaime sold $2.2M of BioMarin Pharmaceutical Inc.

Sold$2,238,000

$111.90Price

20,000Shares

−3%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Fri, Jan 13. Filed Wed, Jan 18, 9:41 PM ET, after the close. Not investment advice.